July 12, 2022 — TheStrathroy Middlesex General Hospital(SMGH) has adoptedMolli— a precise, easy-to-use new technology forbreast cancer localization. Recently, an SMGH team participated in its first breast-conserving surgical procedure using Molli. SMGH is the first hospital in the southwest Ontario region to use this technology.
Molli Surgical’s Health Canada-approved and FDA-cleared Molli features the Molli Marker — the smallest localization marker on the market — and is designed to give a better patient experience over traditional wire localization. TheMolli Wanddetects the marker and visualizes its location on a tablet, helping surgeons locate lesions more efficiently with improved accuracy. Molli is also a great benefit for patients as it allows for more convenient scheduling of marker placement.
“Molli is an innovative and revolutionary way of localizing breast masses that cannot be felt. It allows for a less painful and more effective way of finding the breast disease that needs to be removed, during surgery,” saysDr. Vipan JainMHA普通外科医生。“该标记可以在手术日期前几周插入，使患者更容易安排，并且在手术中不会失去信号，使其成为比放射性种子指南更好的选择。一旦放置，其移动和/或脱出的可能性几乎不存在，这使其成为比传统导丝更好的选择。我们看到了这些好处，而且在手术室使用方便，我相信Molli对患者来说是一个更好的选择。”
“Congratulations to the team at SMGH and Molli Surgical for bringing this innovative, precision technology to our community — and for the difference it will make for Strathroy patients and for their families,” saidJoanne Vanderheyden, Mayor ofStrathroy-Caradoc.
Molli Surgical的总裁兼首席执行官Fazila Seker说:“我们非常高兴能够尽自己的一份力量，帮助Strathroy Middlesex General Hospital使用Molli来改善患者的体验。”“我们相信，通过改善我们对接受乳房手术患者的护理方式，再加上提高放射科和外科部门的效率，为医生和病人创造了更好的整体体验，并最终加强了医院和他们所服务的社区。”
For more information:http://mollisurgical.com/
August 16, 2022
